Conversational artificial-intelligence (AI) solutions provider Hyro has started to provide US hospitals and other medical providers with AI-powered virtual assistants.

This is expected to aid in the management of the mass-scheduling of Covid-19 vaccinations while also mitigating the spread of misinformation regarding the new vaccines’ safety and efficacy.

Hyro’s Vaccine Access Solution, called VAXA, was made in response to the emergency use authorisations issued by the US Food and Drug Administration on 11 and 18 December.

The authorisations allowed the distribution of the Covid-19 vaccines produced by Pfizer-BioNTech and Moderna.

Due to the authorisations, healthcare organisations are expected to see a 500% increase in the normal call volumes as the patients hope to receive fact-checked information, assess eligibility, and book earliest-possible appointments for the vaccinations.

According to the company, the centres with the solution can see that around 40% of the vaccine appointment requests and questions will be deflected to the AI assistants, within the first week of implementation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Additionally, it is expected that there will be a decrease of 65% in the number of callers who hang up after being on hold, unable to reach an agent.

Hyro CEO Israel Krush said: “The concern is that many who are eager to receive the vaccine will be put on hold for such a long time due to call-volume overload that they’ll hang up before getting the answers they seek or, more significantly, hang up without having scheduled a vaccination.”

“As a result, we could see fewer people than hoped for being immunised, which might actually prolong the coronavirus pandemic.”